KEYNOTE-033: Phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (NSCLC)-MedSci.cn

KEYNOTE-033: Phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (NSCLC)

Zhou, C; Caglevic, C; Zhou, J; Wang, B; Wang, K; Ge, J; Zhou, Y; Piperdi, B; Ma, Z

ANNALS OF ONCOLOGY, 2017; 28 ( ): 143

科室
- - 订阅+
  - 更多科室
工具
服务